International Society of Geriatric Oncology

www.siogconference.org

 

19th Conference of the International Society of Geriatric Oncology
T

Polypharmacy or Mobility Assessment in Patients With Haematological Malignancies: Polypharmacy Is Highly Prevalent and Prognostic, Impaired Mobility Is Prognostic, Medications May Impact Mobility

By 19th Conference of the International Society of Geriatric Oncology FEATURING Tanya Wildes
By 19th Conference of the International Society of Geriatric Oncology FEATURING Tanya Wildes
0 views
January 17, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn
Hematologic Oncology
11:32
19th Conference of the International Society of Geriatric Oncology

Polypharmacy or Mobility Assessment in Patients With Haematological …

Feat. T. Wildes
03:59
19th Conference of the International Society of Geriatric Oncology

75 y/o Female with AML: Geriatric Assessment and Management of Lower…

Feat. M. Loh
15:58
19th Conference of the International Society of Geriatric Oncology

AML in Older Adults: Should Intensive Therapy be Considered?

Feat. H. Klepin
11:27
19th Conference of the International Society of Geriatric Oncology

AML at Advanced Age: Non-Intensive Therapy with HMA (Azacitinide) Ma…

Feat. R. Stauder
03:16
19th Conference of the International Society of Geriatric Oncology

80 y/o Female with Limited Stage DLBCL: The Role of Chemo and Radiat…

Feat. K. Christofyllakis
10:41
19th Conference of the International Society of Geriatric Oncology

Non-Hodgkin Lymphoma in Older Patients: Need to Identify Fit Patient…

Feat. R. Cordoba
07:34
19th Conference of the International Society of Geriatric Oncology

The Role of Radiotherapy in Older Adults with DLBCL: R-CHOPx 3/4 +IS…

Feat. N. Vanderwalde